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Radiation-induced fibrosis (RIF) is a major side effect of radiotherapy in cancer patients with no effective therapeutic options. RIF involves excess deposition and aberrant remodeling of the extracellular matrix (ECM) leading to stiffness in tissues and organ failure. Development of preclinical models of RIF is crucial to elucidate the molecular mechanisms regulating fibrosis and to develop therapeutic approaches. In addition to radiation, the main molecular perpetrators of fibrotic reactions are cytokines, including transforming growth factor-b (TGF-b). We hypothesized that human oral fibroblasts would develop an in vitro fibrotic reaction in response to radiation and TGF-b. We demonstrate here that fibroblasts exposed to radiation followed by TGF-b exhibit a fibrotic phenotype with increased collagen deposition, cell proliferation, migration and invasion. In this in vitro model of RIF (RIF iv ), the early biological processes involved in fibrosis are demonstrated, along with increased levels of several molecules including collagen 1a1, collagen XIa1, integrin-a2 and cyclin D1 mRNA in irradiated cells. A clinically relevant antifibrotic agent, pentoxifylline, and a curcumin analogue both mitigated collagen deposition in irradiated fibroblast cultures. In summary, we have established an in vitro model for RIF that facilitates the elucidation of molecular mechanisms in radiation-induced fibrosis and the development of effective therapeutic approaches. Ó 2018 by Radiation Research Society
INTRODUCTION
Radiation therapy is a common treatment of head and neck cancer, either alone or in combination with surgery and/or chemotherapy. Radiation induces damage in both tumor cells and surrounding tissue. Patients tend to develop significant long-term sequelae due both to direct changes in cell function and indirect responses to tissue injury. The presence of cytokines and inflammatory mediators contributes to the chronicity of radiation injury and can lead to radiation-induced fibrosis (RIF) (1) . RIF is a common late complication of radiation therapy and may not manifest for several months after treatment. In the head and neck, fibrosis can lead to trismus, xerostomia, decreased vocal quality, osteoradionecrosis, dysphagia and aspiration, which all significantly affect quality of life (1, 2) .
Initial inflammation triggered by radiation causes fibroblasts to proliferate, migrate and transdifferentiate into myofibroblasts. These fibroblasts produce excess collagen, which is in abundance in the fibrotic region (3) . A variety of growth factors have been implicated in fibrosis. Specifically, TGF-b, a key factor secreted by immune cells and fibroblasts, has been observed in both experimental and clinical studies to be a potent and primary chemotactic mediator of RIF (4) (5) (6) (7) (8) (9) . Among the pathophysiological roles of TGF-b, induction of ECM expression is one of the critical steps of fibrosis (10) (11) . In published in vivo studies, increased TGF-b expression was reported in irradiated mouse skin with noted upregulation of a TGF-b receptor (12) . However, understanding of additional molecular mechanisms and therapeutic targeting thereof has been limited by the lack of an in vitro model.
Based on these observations, we hypothesized in vitro radiation exposure and TGF-b stimulation would recapitulate the fibrotic phenotype. We assessed collagen deposition, cell proliferation, anchorage-independent growth, migration and invasion of oral fibroblasts under these circumstances, and determined this to be a useful in vitro model of RIF (RIF iv ). We demonstrate RIF iv to be useful in understanding early biological mediators of fibrosis, and as a model to assess therapeutic compounds.
MATERIALS AND METHODS

Cell Culture and Reagents
Multiple lines of primary human oral fibroblasts were isolated from cancer-free patient samples, as described elsewhere (13) . Briefly, cells were isolated from patient tonsillar or uvulopalatoplasty specimens by mincing the samples into less than 1-mm sections, and adhering to cell culture dish. Patient samples were collected under the auspices of the Biospecimen Repository Core at the University of Kansas Cancer Center, with written consent from patients, using protocols approved by the Human Subjects Committee at the University of Kansas Medical Center. Cells were cultured in 4.5 g/l glucose DMEM with 10% heat-inactivated fetal bovine serum (FBS; Invitrogene, Carlsbad, CA) without antibiotics, and maintained for no more than 12 passages. All data presented have been confirmed with at least two different patient-derived fibroblast lines.
Direct Red 80 and picric acid were purchased from Thermo Fisher Scientifice Inc. (Waltham, MA). TGF-b was purchased from SigmaAldricht LLC (St. Louis, MO). TRIzolt was purchased from Life Technologies (Grand Island, NY). Pentoxifylline was obtained from Santa Cruz Biotechnologyt Inc. (Dallas, TX).
In Vitro Induction of Radiation-Induced Fibrosis
Fibroblasts were plated in six-well plates (300,000 cells/well), and pretreated with TGF-b in serum free media for 24 h. Plates were then gamma irradiated (Mark I model 68A cesium-137 source irradiator, dose rate ¼ 2.9 Gy/min; J. L. Shepherd & Associates, San Fernando, CA), and media was replaced with fresh TGF-b in serum-free media. After this, collagen deposition occurred over a 72-h period, at which point the cells were fixed with 75% ethanol. All experiments using RIF iv were confirmed on multiple patient samples.
Collagen Staining
Fixed cells were stained with Direct Red 80 (0.1% in picric acid) for 1 h. Cells were washed with PBS to remove Direct Red 80, air dried at room temperature for 5 min and imaged under light microscopy. To quantitate staining intensity, 0.1 M NaOH was used to free bound Direct Red 80, and then dye suspension was transferred into clean 96-well plates for optical density (OD) at 540 nm emission.
Cell Number
Cell number was measured using the CyQUANTe proliferation kit (Life Technologies) according to the manufacturer's protocol. Briefly, cells were plated (2,000 cells/well) in 96-well plates and assayed 72 h later after various experimental-treatment conditions in serum free media. Cells were lysed at -808C, and CyQUANT dye used to measure relative cell number by fluorescence assessment.
RNA-Sequencing and RT-PCR
Fibroblasts were washed after 72 h of treatment with PBS, lysed in TRIzol and RNA was collected following the manufacturer's protocol. RNA-sequencing (RNA-Seq) was used to obtain gene expression profiles of the vehicle control, irradiated, TGF-b treated or irradiated with TGF-b-treated samples. Samples were sequenced in biological duplicates. Sequencing was performed using the HiSeq 2500 system (Illumina, San Diego, CA) at a 100 bp single read resolution. The sequenced reads were mapped to the human genome (assembly GRCh38.rel77) using STAR software (14) , transcript abundance estimates were generated using Cufflinks software (15) and differential gene expression estimates were calculated using Cuffdiff software (16) . RNA-Seq generated between 44.0 and 56.2 million reads per sample, of which on average 99.8% mapped to the reference genome. The replicate samples were highly correlated with an average Pearson coefficient of 0.99. mRNA levels of collagen 1a1, collagen XIa1, cyclin D1, HGF, integrin a2 and b-actin were analyzed using RT-PCR (sequences in Supplementary Information; http://dx.doi.org/10.1667/ RR14926.1.S1). PCR products were visualized on an agarose gel containing GelRede Nucleic Acid stain. Expression levels were assessed using ImageJ software.
Migration and Invasion Assay
Cell migration was evaluated using in vitro transwell inserts (8 lm pores) (Costart). Fibroblasts were plated in triplicate (50,000 cells/ well) in serum-free media in the insert for migration, or on a layer of Matrigelt (Corning Inc., Corning, NY) (2 mg/ml) for invasion. Outer wells contained DMEM with 12% FBS cell culture media. Cells were simultaneously plated in 96-well plates to assess cell viability. After 24 h, cells that migrated through the insert were fixed and stained with Hema 3 (Fisher Scientific, Hampton, NH). Parallel proliferation was assessed using CyQUANT. The number of migrating cells was normalized to total cell number.
3D Culture Assay
Fibroblasts seeded in ultra-low attachment plates [50,000 cells/well in six-well plate (ref. no. 3471; Corning Inc.)] and treated with TGF-b (100 ng/ml) and/or radiation (3 Gy) in serum-free media. After ten days, cells were imaged at 4003 magnification. The Celigot imaging cytometer (Nexcelom Bioscience LLC, Lawrence, MA) was used to count the number of spheroids and average spheroid diameter.
Immunoblot
Whole-cell lysates were extracted using RIPA lysis buffer and a mixture of protease and phosphatase inhibitors (Minitab; Roche, Basel, Switzerland). Lysates were sonicated on ice, debris removed by centrifugation and supernatants stored at -808C. Sodium dodecyl sulfate-polyacrylamide 12% gels were used to separate proteins, and proteins were transferred to nitrocellulose membranes. Membranes were blocked with Odysseyt blocking buffer (LI-COR, Lincoln, NE) in a 1:1 mixture with PBS 1% Tweent 20 (PBST). Primary antibodies (phospho-MAPK and total MAPK; Cell Signaling Technology Inc., Danvers, MA) were incubated overnight in 1:1 blocking buffer to PBST. Primary antibodies were detected using DyLightt conjugated secondary antibodies [anti-rabbit IgG DyLight 488 (cat. no. 35553) and anti-mouse IgG DyLight 800 (cat. no. 35521); Thermo Fisher]. Protein bands were detected using LI-COR Odyssey protein imaging system.
Computational Molecular Docking
Protein structure of MAPK-3 (ERK-1) was downloaded from RCSB protein data bank (PDB-ID: 4QTB). Ligand [difluorocurcumin (CDF)] was downloaded from PubChem (PubChem-CID: 54597187). Autodock tools were used to prepare protein and ligand files for docking. Molecular docking was performed using AutoDock Vina.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism version 6.03 (La Jolla, CA). Significance in treatment responses was determined using two-tailed Mann-Whitney U testing when comparing collagen deposition data, proliferation, migration, invasion and spheroid assays, and two-tailed student's t test for RT-PCR data. Normality of RT-PCR data was assessed by Shapiro-Wilk testing using R version 3.3.1. Significance was considered at P , 0.05.
RESULTS
Radiation and TGF-b Induce Collagen Deposition in Oral Fibroblasts
Patients who undergo radiotherapy for head and neck cancer receive 54-70 Gy of fractionated radiation at a rate of 1.9-2.2 Gy per day. To optimize conditions for an in vitro model, we tested three different radiation doses: 3, 12 and 48 Gy. To assess fibrosis, we used Direct Red 80 to stain collagen and determined that 3 Gy was sufficient to induce collagen deposition in oral fibroblasts. The 3 Gy dose mimics the biology that would occur with each and every fraction of radiation that a patient receives, and is an appropriate dose in a cell culture model where there is no shielding from surrounding tissue. Furthermore, marked induction of collagen deposition was observed with a single 3 Gy dose, and this was negligibly different from a 12 Gy dose (Supplementary Fig. S1 ; http://dx.doi.org/10.1667/ RR14926.1.S1). The 3 Gy dose offered strong induction of the fibrotic phenotype, whereas a high, single dose of 48 Gy was too damaging to the cells (Supplementary Fig. S1 ). Given the central role of TGF-b signaling in RIF (1), we treated fibroblasts with increasing concentrations of TGF-b (0, 1, 5, 10, 20, 50, 100 ng/ml) and observed an increase in collagen deposition with the presence of TGF-b (Supplementary Fig. S2 ). Clinically, TGF-b serum levels increase after radiotherapy, with a basal level in nonirradiated patients of 7.2 ng/ml, and a significant increase with an upper range of 147 ng/ml in irradiated patients (17) . With the caveat that these studies were in lung cancer patients, we selected a dose of 100 ng/ml in our RIF iv model to mimic this significant increase. Given these initial findings, we developed a model, RIF iv , using radiation and TGF-b to mimic the postirradiation environment and induce a significant increase in collagen deposition (Fig. 1A and B ).
Radiation and TGF-b Enhance Cell Proliferation and Migration
Given that fibrosis is characterized by fibroblast proliferation in addition to ECM deposition (1), we next tested the effects of radiation and TGF-b on cell growth. We treated oral fibroblasts with TGF-b and/or radiation and determined the effect on cell number over 72 h using the CyQUANT proliferation kit. There was a significant increase in relative cell number in the combined radiation and TGF-b treatment group compared to control fibroblasts (P , 0.0001) (Fig. 2A) .
To validate this finding, RT-PCR was performed to quantify the proto-oncogene cyclin D1, which plays an important role in the regulation of G 1 -to S-phase transition in many different cell types. Together with its binding partners, cyclin-dependent kinase 4 and 6, cyclin D1 forms active complexes that promote cell cycle progression by phosphorylating and inactivating the retinoblastoma protein (18) (19) (20) . Interestingly, combination treatment increased cyclin D1 mRNA levels compared to untreated fibroblasts ( Fig. 2B and C) . The increased expression of cyclin D1 indicates greater proliferative activity.
During wound healing, fibroblasts migrate and invade the site of injury to repair tissue damage. To understand the role of migration and invasion in wound healing after irradiation, we investigated the hypothesis that fibrotic fibroblasts acquire a migratory phenotype. Compared to untreated fibroblasts, we observed an almost sevenfold increase in cell migration in the combined radiation and TGF-b treatment group (P ¼ 0.0006) and an almost fivefold change in invasion through Matrigel in the combined treatment group (P ¼ 0.0006) (Fig. 2D and E) . The increased propensity of fibrotic cells to proliferate, migrate and invade indicates that this RIF iv model simulates the injury-like nature of this pathology. 
Radiation and TGF-b Enhance Spheroid Formation of Oral Fibroblasts under Anchorage-Independent Conditions
Previous in vitro studies of fibroblasts derived from areas of fibrosis such as interstitial lung disease or fibroblasts treated by radiation have demonstrated the ability of these fibroblasts to form spheroids under anchorage-independent conditions (21, 22) . Further exposure of fibroblasts to fibrosis-inducing agents induces an activated phenotype that includes increased a-SMA and collagen type I expression (23) . In an anchorage-independent environment, we observed that the combination of radiation and TGF-b triggered a significant sixfold increase (P ¼ 0.0022) in the number of spheroids compared to untreated fibroblasts ( Fig.  3A and B) . In addition, the average diameter of the spheres was significantly greater than control fibroblasts (P ¼ 0.0022) (Fig. 3C) . Furthermore, spheroids formed from cells treated with the combination of radiation and TGF-b had significantly higher collagen deposition (P , 0.0001) compared to untreated fibroblasts (Fig. 3D) as assessed using Direct Red 80 staining. The increase in spheroids, their diameter and increase in collagen deposition in the combined treatment group indicates an induction of the fibrotic phenotype.
Radiation and TGF-b Increase Collagen and Integrin Gene Expression and Decreases Hepatocyte Growth Factor Gene Expression in Oral Fibroblasts
RNA-Seq was used to assess the underlying molecular mechanisms of the fibrosis phenotype. Differentially regulated genes in oral fibroblasts treated with the combinations of radiation and TGF-b were studied and compared. Figure 4A shows the heat map of differentially   FIG. 2 . Radiation-and TGF-b-enhance fibroblast proliferation and migration. Panel A: Fibroblasts exposed to 3 Gy and/or treated with TGF-b (100 ng/ml) over 72 h demonstrate an increase in relative cell number (P , 0.0001; graph represents three replicate experiments plated in triplicate). Panels B and C: Expression of cyclin D1 as determined by RT-PCR (panel B) and quantified using densitometry analysis of cyclin D1 expression (panel C; P ¼ 0.05, graph represents ImageJ densitometry analyses of three PCR analyses, and indexed to untreated group). Fibroblasts were assessed for their ability to migrate through a Boyden chamber (panel D) and invade a Matrigel matrix (panel E). Migration and invasion graphs represent three replicate experiments plated in triplicate normalized to parallel proliferation, and indexed to untreated group. Two-tailed Mann-Whitney tests were used to calculate P values. Error bars on all graphs represent 6SEM. expressed genes in the four different treatment groups, grouped into hierarchical clusters. These data were analyzed using QIAGEN's Ingenuityt Pathway Analysis (IPA) and a network of fibrosis regulator genes was created to visualize upregulation and downregulation of genes in pathways associated with TGF-b (Fig. 4B) . Notable changes included upregulation of collagen XIa1, collagen 1a1, integrin-a2b1 and downregulation of hepatocyte growth factor (HGF) in the cells treated with the combination of radiation and TGFb. To validate these findings, RT-PCR was performed, and demonstrated that fibroblasts treated with radiation and TGF-b increased levels of collagen XIa1, collagen 1a1 and integrin-a2 expression (Fig. 5A-F) . RT-PCR also validated a decrease in HGF expression ( Fig. 5G and H) . Furthermore, our RNA-Seq analyses showed an upregulation in mTORC2 gene, which may suggest increased cell metabolism in the group treated with radiation and TGFb (Fig.  4B) .
FIG. 5.
Radiation and TGF-b modulate gene expression in oral fibroblasts. RT-PCR followed by densitometry quantification demonstrate that radiation (3 Gy) combined with TGF-b (100 ng/ml) increases levels of collagen XIa1 (panels A and B), collagen 1a1 (panels C and D) and integrin-a2 (panels E and F), while significantly decreasing the levels of HGF (panels G and H). Gene expression was normalized to b-actin levels. Graphs represent three independent experiments and are indexed to control group. P values were determined using t test with confirmation of normality using Shapiro-Wilk test. Error bars represent 6SEM.
Pentoxifylline and Curcumin Reduce Radiation-Induced Fibrosis in Oral Fibroblasts
Currently, there are no proven treatment options for RIF. The effects of anti-fibrotic agents, such as pentoxifylline, have been studied in previous, as well as ongoing trials. In preliminary studies, pentoxifylline alone or in combination with other antioxidants has demonstrated a modest therapeutic effect in patients affected by RIF (24) (25) (26) . To assess the efficacy of pentoxifylline in mitigating collagen deposition, increasing concentrations of pentoxifylline (0, 2, 20 and 100 lg/ml) were applied to cells after combined radiation and TGF-b treatment. With concentrations greater than 20 lg/ml of pentoxifylline, we observed a moderate but significant reduction in collagen deposition using Direct Red 80 staining (P ¼ 0.0022) compared to untreated fibroblasts ( Fig. 6A and B ; radiation and TGF-b alone data not shown), suggesting a concentration-dependent reduction in collagen deposition.
We also assessed curcumin-difluorinated (CDF), a derivative of the phytochemical curcumin (27) . Among many phytochemical agents, curcumin has shown promising antineoplastic properties (28, 29) . Several research studies over the last few decades have established curcumin as a potent anti-inflammatory agent with therapeutic potential against a variety of cancers and may inhibit the fibrotic process (30) (31) (32) (33) (34) (35) (36) . However, given its low bioavailability and rapid metabolism, analogs such as CDF have been synthesized to improve its therapeutic utility (27) . As such, fibroblasts were treated with increasing concentrations of CDF (0, 1, 5, 10 and 20 lM) after combined radiation and TGF-b treatment. There was a significant decrease in collagen deposition as assessed by Direct Red 80 staining with the use of 5, 10 and 20 lM of CDF ( Fig. 6C and D ; radiation and TGF-b alone data not shown). To elucidate the mechanism of CDF, we assessed binding to MAPK, a common signal transduction component of both TGF-b and integrin signaling. Computational molecular docking analyses demonstrated high binding affinity (-11.6 Kcal/mol) in the catalytic domain of MAPK (Supplementary Fig. S3A and B; http://dx.doi.org/10.1667/RR14926.1.S1). This was validated by immunoblot, where CDF alleviated MAPK phosphorylation after TGF-b treatment (Supplementary Fig.  S3C ). These findings indicate CDF may be effective in reducing RIF.
DISCUSSION
RIF is a complex and progressive tissue response to injury characterized by constant remodeling and long-term fibroblast activation (37, 38) . After the direct DNA damage resulting from radiation, an acute inflammatory response is triggered. Due to lasting cellular dysfunction from the initial radiotherapy, the inflammatory response persists with an increase in multiple cytokines and growth factors (37) (38) (39) (40) . A long list of inflammatory mediators such as tumor necrosis factor-a (TNF-a), interleukin (IL) 1 (IL-1), IL-6 and a plethora of growth factors play a role in the fibrotic process (38, (40) (41) (42) (43) (44) . By far, TGF-b has been established as playing a critically central role in RIF. Its involvement has been addressed in various irradiated tissues, mostly through in vivo experiments of skin, intestine, liver, mammary gland and lung (1-3, 6-9, 12, 37, 38, 44) . In the head and neck region, this inflammatory response leads to long-term fibroblast activation, which then leads to progressive stiffening of the connective tissues that can further devastate quality of life (45, 46) . Developing strategies to prevent and treat long-term fibrotic complications would greatly aid in improving patient quality of life.
The previous succession of experiments replicates the fibrosis phenotype in oral fibroblasts leading to a novel in vitro model that can be used for further testing of the processes involved in RIF. In our study, multiple fibroblast lines were cultured from tonsil tissue of cancer-free patients using previously established tissue culture models.
In our RIF iv model, stimulated fibroblasts were noted to have increased collagen deposition, a hallmark of fibrosis. IPA revealed an upregulation of genes for collagen 1a1 and collagen XIa1 in these fibroblasts. Alteration in the collagen XIa1 gene has been associated with several connective tissue disorders and is a downstream target of the TGF-b signaling pathway (47) (48) (49) (50) . While clinical fibrosis takes months to years to develop, the pathophysiology of fibrosis starts with the initiation of each and every radiation dose. This RIF iv model represents the early biological processes involved in fibrosis and can be used to elucidate the early mechanisms that cause the continuation of fibrosis.
Additionally, we observed an increase in cyclin D1 expression. Previous in vitro studies suggest that cyclin D1 regulates cell proliferation in fibrotic tissues, such as idiopathic pulmonary fibrosis (51, 52) . Furthermore, using IPA, we observed an upregulation of mTORC2, which regulates cellular metabolism, growth and proliferation (Fig.  4B) . A previous study of fibroblasts implicated in kidney fibrosis demonstrated TGF-b induced mTORC2 signaling activation, and reciprocally mTORC2 signaling contributes to TGF-b promoted fibroblast activation (53) . The previous observations and our current findings together suggest that in RIF not only do cells deposit more collagen but also proliferate with high metabolic activity.
A significant upregulation in the expression of integrina2b1 was observed, which likely gives a partial mechanism to the increased migration and spheroid formation observed. Integrin-a2b1 plays an important role in the movement of fibroblasts along collagen fibrils. Fibroblasts interact with surrounding collagen mainly using receptors of the b1 family of integrins (54) . Previous studies demonstrate that fibroblasts exposed to a rich ECM use integrin-a2b1 to form focal contacts on collagens to support migration in response to chemotactic stimuli (54) (55) (56) . More recently reported evidence suggests a reciprocal connection between integrins and the TGF-b pathway (54) . While radiation alone and TGF-b alone were noted to cause minimal increases in collagen deposition, cell proliferation, migration, invasion and ability to form spheroids, the combination together resulted in a significant change in fibroblast activity.
Interestingly, although HGF has been established as upregulated in the HNSCC tumor microenvironment (57), HGF was downregulated in our system after irradiation. Along with its role in embryonic development, there is emerging evidence that HGF is an anti-fibrotic factor that FIG. 6. Pentoxifylline and CDF decrease collagen deposition. Cells exposed to radiation (3 Gy) and TGF-b (100 ng/ml) were assessed for collagen deposition after treatment with antifibrotic agents. Cells in various treatment groups were stained with Direct Red 80, imaged under light microscopy and the OD quantified and graphed. Increasing concentrations of pentoxifylline (panels A and B) or CDF (panels C and D) reduced the level of collagen deposition in the cultures. Collagen levels in each treatment arm were normalized to cell number. Graphs represent relative collagen deposition of three independent experiments plated in duplicate. Two-tailed Mann-Whitney tests were used to calculate P values. Error bars represent 6SEM.
plays a critical role in preventing tissue fibrosis. In vitro studies have observed that HGF counteract many profibrotic actions of TGF-b, suggesting the balance between the two may play a role in fibrosis development (58) (59) (60) (61) (62) . After initial acute injury, both HGF and TGF-b are induced, but if the injury is chronic in nature, TGF-b expression progressively increases, with a gradual decrease in HGF levels. Thus, in chronic injury states, such as those created via radiation damage, the balance shifts to favor the profibrotic TGF-b (61, 63) . Noting a decrease in the expression of HGF in the current study further lends credence to this RIF iv model.
Given that our RIF iv model replicates the early radiationinduced fibrosis phenotype damage and is concurrent with previously performed experiments, it can thus be used to test anti-fibrotic agents. Although we focus on head and neck fibroblasts, this model is potentially useful in studying fibrosis with fibroblasts from other anatomical locations, such as lung, breast and liver. Clinically, it is important to mitigate fibrosis early in its development. We tested both pentoxifylline, which is currently FDA approved for chronic occlusive arterial disease, and the curcumin analogue CDF, and noted a decrease in collagen deposition after treatment with each agent. Further studies on the mechanism of CDF function are warranted and are the subject of a current investigation. (-11.6 Kcal/mol) of docked structure predicted by AutoDock-Vina demonstrates amino acid residues (ILE48, GLY49, GLU50, TYR53, VAL56, ALA69, LYS71, LEU124, MET125 and LEU173) involved in interaction and is displayed in ball and stick and CPK style (panels A and B, respectively). Green lines indicate the hydrogen bonding between residues with CDF. Panel C: Immunoblot of phospho-p44/42 MAPK and total p44/42 MAPK of primary fibroblasts treated with TGF-b (10 ng/ml) and/or CDF (10 lM) demonstrates increased phosphorylation with TGF-b, which is inhibited by CDF treatment.
